Candel Therapeutics, Inc. (CADL)’s CAN-2409 Advances with FDA RMAT Status for Localized Prostate Cancer
Candel Therapeutics, Inc.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Portolan Capital Management George Mccabe | 3,490,398 | $35,951,099 | +21% | 1.35% |
| 2. | Saturn V Capital Management Xiaoying Tian | 3,303,686 | $34,027,966 | +15% | 4.88% |
| 3. | Millennium Management Israel Englander | 1,093,905 | $11,267,222 | +4% | 0% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 300,641 | $3,096,603 | 0% | |
| 5. | Citadel Investment Group Ken Griffin | 146,016 | $1,503,965 | +101% | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.45 | 550,458 | $2,999,996.10 | 2,763,527 | 2026-02-23 | Filing | |
| $6.00 | 750,000 | $4,500,000.00 | 1,303,752 | 2024-12-16 | Filing | |
| $6.00 | 500,000 | $3,000,000.00 | 1,142,406 | 2024-12-16 | Filing | |
| $1.92 | 23,950 | $45,984.00 | 152,000 | 2022-12-09 | Filing | |
| $1.68 | 3,050 | $5,124.00 | 128,050 | 2022-12-08 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.46 | 59,379 | $620,890.58 | 113,321 | 2026-09-11 | Filing | |
| $11.50 | 220,866 | $2,539,892.74 | 172,700 | 2026-09-10 | Filing | |
| $12.00 | 7,000 | $84,000.00 | 76,865 | 2026-08-17 | Filing | |
| $10.06 | 23,447 | $235,768.96 | 77,362 | 2026-06-29 | Filing | |
| $10.02 | 7,000 | $70,151.20 | 83,865 | 2026-06-29 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 198,175 | $2,068,947 | 0.17% | |
| 2. | 88,097 | $919,733 | 0.03% | |
| 3. | 67,802 | $707,853 | 0% | |
| 4. | 33,301 | $347,662 | 0.01% | |
| 5. | 13,962 | $151,907 | 0.01% |